Skip to main content

Free Content Seroprevalence of Q-fever in febrile individuals in Mali

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library


Summary Objectives 

We conducted a serological survey for Q-fever among febrile patients in Bamako and Mopti (Mali) and investigated the main risk factors for seroconversion. Methods 

Blood samples from 156 febrile patients were collected in healthcare facilities of Bamako and Mopti and examined with the microimmunofluorescence test. Results 

Forty per cent (n = 63) were seropositive for Q-fever, 28% in Bamako and 51% in Mopti. A more recent infection was suspected in 9.5% (n = 6) of all seropositive patients. This is the first time that Q-fever seropositivity is reported in febrile individuals in Mali. The patients’ symptoms and diagnoses spanned a wide range of conditions; none had been diagnosed with Q fever by their treating physician. No risk factors for seropositivity could be identified with the exception of the city of residence and none could be identified with a logistic regression model with ‘city’ taken as random effect. Conclusion 

A high rate of seropositivity to C. burnetii was found among febrile urban patients in Mali but no risk factors for seropositivity could be identified in this study.

Keywords: Mali; Q-fever; microimmunofluorescence; risk factors; seropositivity

Document Type: Research Article


Affiliations: 1: Swiss Tropical Institute, Basel, Switzerland 2: Institut Central des Hôpitaux Valaisans, Maladies infectieuses et microbiologie, Sion, Switzerland 3: Clinique ‘Dr Yamadon Sidibe’, Bamako, Mali

Publication date: June 1, 2005


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more